Imugene Limited Stock Market Value
| IUGNF Stock | USD 0.24 0.06 33.33% |
| Symbol | Imugene |
Imugene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Imugene's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Imugene.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Imugene on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Imugene Limited or generate 0.0% return on investment in Imugene over 90 days. Imugene is related to or competes with Starpharma Holdings, Satellos Bioscience, Biostem Technologies, VitaSpring Biomedical, and Kintor Pharmaceutical. Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune sy... More
Imugene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Imugene's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Imugene Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.25 | |||
| Information Ratio | 0.0213 | |||
| Maximum Drawdown | 47.15 | |||
| Value At Risk | (13.04) | |||
| Potential Upside | 25.0 |
Imugene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Imugene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Imugene's standard deviation. In reality, there are many statistical measures that can use Imugene historical prices to predict the future Imugene's volatility.| Risk Adjusted Performance | 0.0329 | |||
| Jensen Alpha | 0.1043 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.0222 | |||
| Treynor Ratio | 0.1443 |
Imugene January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0329 | |||
| Market Risk Adjusted Performance | 0.1543 | |||
| Mean Deviation | 6.18 | |||
| Semi Deviation | 6.38 | |||
| Downside Deviation | 9.25 | |||
| Coefficient Of Variation | 3114.13 | |||
| Standard Deviation | 9.63 | |||
| Variance | 92.78 | |||
| Information Ratio | 0.0213 | |||
| Jensen Alpha | 0.1043 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.0222 | |||
| Treynor Ratio | 0.1443 | |||
| Maximum Drawdown | 47.15 | |||
| Value At Risk | (13.04) | |||
| Potential Upside | 25.0 | |||
| Downside Variance | 85.61 | |||
| Semi Variance | 40.7 | |||
| Expected Short fall | (12.31) | |||
| Skewness | 1.2 | |||
| Kurtosis | 2.77 |
Imugene Limited Backtested Returns
Imugene appears to be out of control, given 3 months investment horizon. Imugene Limited holds Efficiency (Sharpe) Ratio of 0.0608, which attests that the entity had a 0.0608 % return per unit of risk over the last 3 months. By evaluating Imugene's technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize Imugene's Downside Deviation of 9.25, market risk adjusted performance of 0.1543, and Risk Adjusted Performance of 0.0329 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Imugene holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of 2.07, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Imugene will likely underperform. Please check Imugene's value at risk and the relationship between the expected short fall and period momentum indicator , to make a quick decision on whether Imugene's current trending patterns will revert.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Imugene Limited has insignificant reverse predictability. Overlapping area represents the amount of predictability between Imugene time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Imugene Limited price movement. The serial correlation of -0.18 indicates that over 18.0% of current Imugene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Imugene Pink Sheet
Imugene financial ratios help investors to determine whether Imugene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imugene with respect to the benefits of owning Imugene security.